Literature DB >> 10843151

Gender differences in the prevalence of metabolic complications in familial partial lipodystrophy (Dunnigan variety).

A Garg1.   

Abstract

Familial partial lipodystrophy, Dunnigan type (FPLD; Mendelian Inheritance in Man #151660), is an autosomal dominant disorder characterized by loss of s.c. fat from the extremities and trunk since puberty and predisposition to insulin resistance and its complications. However, for lack of recognition of affected men, previous studies could not ascertain any gender differences in phenotypic expression. Therefore, anthropometric variables and prevalence of diabetes mellitus, dyslipidemia, hypertension, and atherosclerotic vascular disease were compared among 17 postpubertal men and 22 women with FPLD from eight pedigrees. All individuals completed a questionnaire, and fasting blood was analyzed for glucose, insulin, and lipoprotein concentrations. Both affected men and women had similar patterns of fat loss. Compared with the affected men, women had higher prevalence of diabetes (18% and 50%, respectively; P = 0.05) and atherosclerotic vascular disease (12% and 45%, respectively; P = 0.04) and had higher serum triglycerides (median values, 2.27 and 4.25 mmol/L, respectively; P = 0.02) and lower high-density lipoprotein cholesterol concentrations (age-adjusted means, 0.94 and 0.70 mmol/L, respectively; P = 0.04). The prevalence of hypertension and fasting serum insulin concentrations were similar. In conclusion, women with FPLD are more severely affected with metabolic complications of insulin resistance than men. These observations raise the possibility that women with generalized and regional obesity may also have more severe metabolic sequelae of insulin resistance.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10843151     DOI: 10.1210/jcem.85.5.6605

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  40 in total

Review 1.  Lipoatrophic diabetes and other related syndromes.

Authors:  Elif Arioglu Oral
Journal:  Rev Endocr Metab Disord       Date:  2003-03       Impact factor: 6.514

Review 2.  Lipodystrophy: pathophysiology and advances in treatment.

Authors:  Christina G Fiorenza; Sharon H Chou; Christos S Mantzoros
Journal:  Nat Rev Endocrinol       Date:  2010-11-16       Impact factor: 43.330

3.  A Novel LMNA Mutation Causes Altered Nuclear Morphology and Symptoms of Familial Partial Lipodystrophy (Dunnigan Variety) with Progeroid Features.

Authors:  B Saha; D Lessel; F M Hisama; D F Leistritz; K Friedrich; G M Martin; C Kubisch; J Oshima
Journal:  Mol Syndromol       Date:  2010-09-14

Review 4.  Laminopathies and the long strange trip from basic cell biology to therapy.

Authors:  Howard J Worman; Loren G Fong; Antoine Muchir; Stephen G Young
Journal:  J Clin Invest       Date:  2009-07-01       Impact factor: 14.808

Review 5.  Lipodystrophy syndromes.

Authors:  Pedro Herranz; Raul de Lucas; Luis Pérez-España; Matias Mayor
Journal:  Dermatol Clin       Date:  2008-10       Impact factor: 3.478

6.  Leptin therapy in lipodystrophy.

Authors:  D B Savage; S O'Rahilly
Journal:  Diabetologia       Date:  2009-10-04       Impact factor: 10.122

7.  The clinical approach to the detection of lipodystrophy - an AACE consensus statement.

Authors:  Yehuda Handelsman; Elif A Oral; Zachary T Bloomgarden; Rebecca J Brown; Jean L Chan; Daniel Einhorn; Alan J Garber; Abhimanyu Garg; W Timothy Garvey; George Grunberger; Robert R Henry; Norman Lavin; Carmen D Tapiador; Christian Weyer
Journal:  Endocr Pract       Date:  2013 Jan-Feb       Impact factor: 3.443

Review 8.  Adipose tissue biology and cardiomyopathy: translational implications.

Authors:  Aslan T Turer; Joseph A Hill; Joel K Elmquist; Philipp E Scherer
Journal:  Circ Res       Date:  2012-12-07       Impact factor: 17.367

9.  Lipodystrophy: an unusual diagnosis in a case of oligomenorrhea and hirsutism.

Authors:  Jennifer Keller; Lalitha Subramanyam; Vinaya Simha; Robert Gustofson; Debra Minjarez; Abhimanyu Garg
Journal:  Obstet Gynecol       Date:  2009-08       Impact factor: 7.661

10.  Novel subtype of congenital generalized lipodystrophy associated with muscular weakness and cervical spine instability.

Authors:  Vinaya Simha; Anil K Agarwal; Patricia A Aronin; Susan T Iannaccone; Abhimanyu Garg
Journal:  Am J Med Genet A       Date:  2008-09-15       Impact factor: 2.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.